Skip to main content
Erschienen in: Translational Behavioral Medicine 1/2017

29.08.2016 | Practice and Public Health Policies

Leveraging corporate social responsibility to improve consumer safety of dietary supplements sold for weight loss and muscle building

verfasst von: Anvita Kulkarni, BA, Ryan Huerto, MD, MPH, Christina A. Roberto, PhD, S. Bryn Austin, ScD

Erschienen in: Translational Behavioral Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The potential dangers associated with dietary supplements sold for weight loss and muscle building are well documented and increasingly garnering the attention of the media, public, and government leaders. Public health professionals have an opportunity to improve population health in the context of dietary supplement use by translating scientific evidence into action. In this commentary, we discuss the potential to motivate corporate social responsibility (CSR) among manufacturers and retailers of dietary supplements sold for weight loss and muscle building. We examine levers available to public health professionals for generating voluntary corporate self-regulation by reviewing examples from successful CSR initiatives in other domains of public health and offering recommendations highlighting effective advocacy strategies. We encourage public health professionals to use one or multiple advocacy strategies to improve consumer protections for dietary supplements sold for weight loss and muscle building.
Literatur
4.
Zurück zum Zitat Neville A. IBIS World Industry Report: Online vitamin and supplement sales in the U.S.; 2015. Neville A. IBIS World Industry Report: Online vitamin and supplement sales in the U.S.; 2015.
5.
Zurück zum Zitat Onakpoya, I. J., Wider, B., Pittler, M. H., & Ernst, E. (2011). Food supplements for body weight reduction: a systematic review of systematic reviews. Obesity, 19(2), 239–244.CrossRefPubMed Onakpoya, I. J., Wider, B., Pittler, M. H., & Ernst, E. (2011). Food supplements for body weight reduction: a systematic review of systematic reviews. Obesity, 19(2), 239–244.CrossRefPubMed
6.
Zurück zum Zitat Cohen, P. A. (2014). Hazards of hindsight—monitoring the safety of nutritional supplements. N Engl J Med, 370(14), 1277–1280.CrossRefPubMed Cohen, P. A. (2014). Hazards of hindsight—monitoring the safety of nutritional supplements. N Engl J Med, 370(14), 1277–1280.CrossRefPubMed
7.
Zurück zum Zitat Pomeranz, J. L., Barbosa, G., Killian, C., & Austin, S. B. (2015). The dangerous mix of adolescents and dietary supplements for weight loss and muscle building: legal strategies for state action. Journal of Public Health Management and Practice, 21(5), 496–503.CrossRefPubMed Pomeranz, J. L., Barbosa, G., Killian, C., & Austin, S. B. (2015). The dangerous mix of adolescents and dietary supplements for weight loss and muscle building: legal strategies for state action. Journal of Public Health Management and Practice, 21(5), 496–503.CrossRefPubMed
8.
Zurück zum Zitat Li, N., Hauser, R., Holford, T., Zhu, Y., Zhang, Y., Bassig, B. A., et al. (2015). Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. Br J Cancer, 112(7), 1247–1250.CrossRefPubMedPubMedCentral Li, N., Hauser, R., Holford, T., Zhu, Y., Zhang, Y., Bassig, B. A., et al. (2015). Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. Br J Cancer, 112(7), 1247–1250.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Delimaris, I. (2013). Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutrition, 2013, 89–94.CrossRef Delimaris, I. (2013). Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutrition, 2013, 89–94.CrossRef
10.
Zurück zum Zitat Geller, A. I., Shehab, N., Weidle, N. J., Lovegrove, M. C., Wolpert, B. J., Timbo, B. B., et al. (2015). Emergency department visits for adverse events related to dietary supplements. N Engl J Med, 373(16), 1531–1540.CrossRefPubMed Geller, A. I., Shehab, N., Weidle, N. J., Lovegrove, M. C., Wolpert, B. J., Timbo, B. B., et al. (2015). Emergency department visits for adverse events related to dietary supplements. N Engl J Med, 373(16), 1531–1540.CrossRefPubMed
11.
Zurück zum Zitat Wilson, K. M., Klein, J. D., Sesselberg, T. S., et al. (2006). Use of complementary medicine and dietary supplements among US adolescents. J Adolesc Health, 38(4), 385–394.CrossRefPubMed Wilson, K. M., Klein, J. D., Sesselberg, T. S., et al. (2006). Use of complementary medicine and dietary supplements among US adolescents. J Adolesc Health, 38(4), 385–394.CrossRefPubMed
12.
Zurück zum Zitat Eisenberg, M. E., Wall, M., & Neumark-Sztainer, D. (2012). Muscle-enhancing behaviors among adolescent girls and boys. Pediatrics, 130(6), 1019–1026.CrossRefPubMedPubMedCentral Eisenberg, M. E., Wall, M., & Neumark-Sztainer, D. (2012). Muscle-enhancing behaviors among adolescent girls and boys. Pediatrics, 130(6), 1019–1026.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Blanck, H. M., Serdula, M. K., Gillespie, C., Galuska, D. A., Sharpe, P. A., Conway, J. M., et al. (2007). Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc, 107, 441–447.CrossRefPubMed Blanck, H. M., Serdula, M. K., Gillespie, C., Galuska, D. A., Sharpe, P. A., Conway, J. M., et al. (2007). Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc, 107, 441–447.CrossRefPubMed
14.
15.
Zurück zum Zitat Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J. (2014). Presence of banned drugs in dietary supplements following FDA recalls. J Am Med Assoc, 312(16), 1691–1693.CrossRef Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J. (2014). Presence of banned drugs in dietary supplements following FDA recalls. J Am Med Assoc, 312(16), 1691–1693.CrossRef
16.
Zurück zum Zitat Cohen, P. A., Attipoe, S., Travis, J., Stevens, M., & Deuster, P. (2013). Caffeine content of dietary supplements consumed on military bases. JAMA Internal Medicine, 173(7), 592–594.PubMed Cohen, P. A., Attipoe, S., Travis, J., Stevens, M., & Deuster, P. (2013). Caffeine content of dietary supplements consumed on military bases. JAMA Internal Medicine, 173(7), 592–594.PubMed
18.
Zurück zum Zitat Cohen, P. A., Travis, J. C., & Venhuis, B. J. (2014). A methamphetamine analog (N,alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis, 6(7–8), 805–807.CrossRefPubMed Cohen, P. A., Travis, J. C., & Venhuis, B. J. (2014). A methamphetamine analog (N,alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis, 6(7–8), 805–807.CrossRefPubMed
19.
Zurück zum Zitat Dahlsrud, A. (2008). How corporate social responsiblity is defined: an analysis of 37 definitions. Corp Soc Responsib Environ Manag, 15(1), 1–13.CrossRef Dahlsrud, A. (2008). How corporate social responsiblity is defined: an analysis of 37 definitions. Corp Soc Responsib Environ Manag, 15(1), 1–13.CrossRef
20.
Zurück zum Zitat Brennan, T. A., & Schroeder, S. A. (2014). Ending sales of tobacco products in pharmacies. J Am Med Assoc, 311(11), 1105–1106.CrossRef Brennan, T. A., & Schroeder, S. A. (2014). Ending sales of tobacco products in pharmacies. J Am Med Assoc, 311(11), 1105–1106.CrossRef
24.
Zurück zum Zitat Waddington, F., Naunton, M., Kyle, G., Thomas, J., Cooper, G., & Waddinton, A. (2015). A systematic review of community pharmacist therapeutic knowledge of dietary supplements. International Journal of Clinical Pharmacology, 37(3), 439–446.CrossRef Waddington, F., Naunton, M., Kyle, G., Thomas, J., Cooper, G., & Waddinton, A. (2015). A systematic review of community pharmacist therapeutic knowledge of dietary supplements. International Journal of Clinical Pharmacology, 37(3), 439–446.CrossRef
27.
Zurück zum Zitat Dorfman, L., Wallack, L., & Woodruff, K. (2005). More than a message: framing public health advocacy to change corporate practices. Health Education and Behavior, 32(3), 320–336.CrossRefPubMed Dorfman, L., Wallack, L., & Woodruff, K. (2005). More than a message: framing public health advocacy to change corporate practices. Health Education and Behavior, 32(3), 320–336.CrossRefPubMed
28.
Zurück zum Zitat Heath, C., & Heath, C. (2007). Made to stick: why some ideas survive and others die. New York: Random House. Heath, C., & Heath, C. (2007). Made to stick: why some ideas survive and others die. New York: Random House.
29.
Zurück zum Zitat Petty, R. E., & Cacioppo, J. T. (1979). Issue involvement can increase or decrease persuasion by enhancing message-relevant cognitive processes. J Pers Soc Psychol, 37, 1915–1926.CrossRef Petty, R. E., & Cacioppo, J. T. (1979). Issue involvement can increase or decrease persuasion by enhancing message-relevant cognitive processes. J Pers Soc Psychol, 37, 1915–1926.CrossRef
30.
Zurück zum Zitat Ratner, R. K., & Riis, J. (2014). Communicating science-based recommendations with memorable and actionable guidelines. Proc Natl Acad Sci U S A, 111(Suppl 4), 13634–13641.CrossRefPubMedPubMedCentral Ratner, R. K., & Riis, J. (2014). Communicating science-based recommendations with memorable and actionable guidelines. Proc Natl Acad Sci U S A, 111(Suppl 4), 13634–13641.CrossRefPubMedPubMedCentral
Metadaten
Titel
Leveraging corporate social responsibility to improve consumer safety of dietary supplements sold for weight loss and muscle building
verfasst von
Anvita Kulkarni, BA
Ryan Huerto, MD, MPH
Christina A. Roberto, PhD
S. Bryn Austin, ScD
Publikationsdatum
29.08.2016
Verlag
Springer US
Erschienen in
Translational Behavioral Medicine / Ausgabe 1/2017
Print ISSN: 1869-6716
Elektronische ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-016-0434-4

Weitere Artikel der Ausgabe 1/2017

Translational Behavioral Medicine 1/2017 Zur Ausgabe